The present invention also provides a process for the preparation of a compound of formula (I), or a pharmaceutically acceptable derivative thereof, comprising either: A. reducing a compound of formula ##STR2## wherein X represents halogen and M is a protecting group; or B. condensing a compound of formula ##STR3## wherein M is defined above, with a compound of formula ##STR4## wherein X and M are